Does SACITUZUMAB GOVITECAN Cause Disease progression? 389 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 389 reports of Disease progression have been filed in association with SACITUZUMAB GOVITECAN (TRODELVY). This represents 30.9% of all adverse event reports for SACITUZUMAB GOVITECAN.
389
Reports of Disease progression with SACITUZUMAB GOVITECAN
30.9%
of all SACITUZUMAB GOVITECAN reports
62
Deaths
55
Hospitalizations
How Dangerous Is Disease progression From SACITUZUMAB GOVITECAN?
Of the 389 reports, 62 (15.9%) resulted in death, 55 (14.1%) required hospitalization, and 6 (1.5%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for SACITUZUMAB GOVITECAN.
What Other Side Effects Does SACITUZUMAB GOVITECAN Cause?
Diarrhoea (184)
Death (182)
Inappropriate schedule of product administration (147)
Neutropenia (128)
Off label use (111)
Fatigue (109)
Febrile neutropenia (92)
Asthenia (90)
Weight decreased (89)
Nausea (87)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which SACITUZUMAB GOVITECAN Alternatives Have Lower Disease progression Risk?
SACITUZUMAB GOVITECAN vs SACITUZUMAB GOVITECAN-HZIY
SACITUZUMAB GOVITECAN vs SACROSIDASE
SACITUZUMAB GOVITECAN vs SACUBITRIL
SACITUZUMAB GOVITECAN vs SACUBITRIL\VALSARTAN
SACITUZUMAB GOVITECAN vs SAFINAMIDE